Ann: Annual Report to shareholders, page-9

Unless of course Immuron are withholding material information from shareholders and the market again.

Not so long ago on the 3/2/20 that a press release (not market release) titled "Immuron's Technology Platform of Treatments in the Age of the Coronavirus Outbreak" was released. A mere tease re. the fact that IMM-124E may hold some efficacy towards "reducing it's incidence". Share price was 13c.

Over the following months the price plummeted to an all time low of 5c without a peep from the CEO/board.

Miraculously on the 21/7/20 it was released that IMM-124E had shown in-vitro success in demonstrating neutralising activity against SARS-CoV-2.

So over 5 months of silence watching the share price plummeting, mug holders selling no doubt at tremendous losses. All the while in-vitro tests were secretively being conducted behind the scene, oh I’m sure those select few knew exactly what was going on scooping up those bargain basement prices. Awaiting the orchestrated pump and dump that followed the 21/7 announcement.

Here we are again completely in the dark as to what is going on.

I for one am over this scam/charade whatever you want to call it. Time to expose this for what it is. Of course this is only my opinion so it’s time to seek an official ruling on the companies conduct.

I’m done with being played.